Over six decades after its initial introduction, the drug naltrexone is making headlines once again, proving its versatility beyond its original purpose as an opioid antagonist. What happened Initially approved by the FDA in 1984, naltrexone was designed to treat opioid addiction by blocking the effects of opiates on the brain. However, recent studies have…
What happened The internet is rife with “choose one, lose the rest” scenarios that challenge our preferences and priorities. From food cravings to entertainment choices, these scenarios invite us to engage in thought-provoking decisions, reflecting our values and desires. In recent months, this trend has become a social phenomenon, leading discussions across various platforms. Here’s…
In an innovative move to disrupt conventional notions of play, a new interactive archive has emerged, celebrating a diverse array of projects themed around ‘unruly play’. This initiative encourages creativity, experimentation, and the embracing of imperfection in various forms of artistic expression. The archive serves as a valuable resource for artists, educators, and the broader…
The latest turn In recent weeks, the future of the famed Elephant Tree in Potsdam has increasingly come into question as a series of regulatory assessments weigh its ecological importance against urban development interests. Local authorities announced a public consultation set for next month, where citizens will have the chance to voice their views and…